1. Home
  2. GLP vs ANAB Comparison

GLP vs ANAB Comparison

Compare GLP & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Partners LP

GLP

Global Partners LP

HOLD

Current Price

$48.46

Market Cap

1.5B

Sector

Energy

ML Signal

HOLD

ANAB

AnaptysBio Inc.

HOLD

Current Price

$52.99

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLP
ANAB
Founded
2005
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2005
2017

Fundamental Metrics

Financial Performance
Metric
GLP
ANAB
Price
$48.46
$52.99
Analyst Decision
Hold
Buy
Analyst Count
1
11
Target Price
$45.00
$60.18
AVG Volume (30 Days)
46.4K
441.9K
Earning Date
02-27-2026
03-02-2026
Dividend Yield
6.24%
N/A
EPS Growth
N/A
N/A
EPS
2.08
N/A
Revenue
$18,099,776,000.00
$169,467,000.00
Revenue This Year
$22.70
$135.51
Revenue Next Year
$42.12
N/A
P/E Ratio
$23.43
N/A
Revenue Growth
4.10
196.42
52 Week Low
$39.58
$13.99
52 Week High
$60.00
$57.65

Technical Indicators

Market Signals
Indicator
GLP
ANAB
Relative Strength Index (RSI) 66.88 59.78
Support Level $45.85 $46.85
Resistance Level $47.75 $56.39
Average True Range (ATR) 1.24 3.61
MACD 0.12 0.48
Stochastic Oscillator 90.62 64.57

Price Performance

Historical Comparison
GLP
ANAB

About GLP Global Partners LP

Global Partners LP is a limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the Wholesale segment.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: